The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Economic modelling to inform pricing for LMICs of immune checkpoint inhibitors in advanced PD-L1-high non-small cell lung cancer.
 
Giulia Segafredo
No Relationships to Disclose
 
Dario Trapani
No Relationships to Disclose
 
Manju Sengar
No Relationships to Disclose
 
Paul Ruff
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Janssen Oncology (Inst); MSD (Inst); NantWorks (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Esteban Burrone
No Relationships to Disclose
 
Hannah Schirrmacher
Consulting or Advisory Role - AstraZeneca, Novo Nordisk, MSD, Sanofi (Inst)
 
Konstantina Politopoulou
Consulting or Advisory Role - AstraZeneca, Novo Nordisk, MSD, Sanofi (Inst)
 
Chrissy Bishop
Consulting or Advisory Role - AstraZeneca, Novo Nordisk, MSD, Sanofi. (Inst)
 
Federico Cairoli
Consulting or Advisory Role - AstraZeneca, Novo Nordisk, MSD, Sanofi (Inst)
Research Funding - AstraZeneca, Novo Nordisk, MSD, Sanofi (Inst)